Pentagon creates biotech office to fast-track military research partnerships
H.R. 6664 — To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes. · Filed by Joe Neguse (D-CO) · Introduced Dec 11, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a new Biotechnology Management Office within the Department of Defense, led by a senior official with biotech expertise, to coordinate military research and development of biotechnology and bioindustrial manufacturing. The office will develop long-term roadmaps, update acquisition policies, partner with industry and academia, and streamline regulatory processes for biotech adoption in the military—with a sunset date of September 30, 2030.
Why we flagged it
The bill's primary function is to establish a new DoD office tasked with coordinating biotechnology research, development, and acquisition across military and civilian partners. It is fundamentally an organizational and policy-coordination measure, not a direct appropriation or subsidy, though it authorizes use of existing R&D funds.
What the text implies
- The office's authority to 'streamline regulatory or acquisition processes' may reduce public-health or environmental review timelines for dual-use biotech products, potentially accelerating deployment of biotechnology with limited civilian oversight.
- Public-private partnerships and 'regionally focused innovation ecosystems' may create preferential access for private biotech firms to military R&D funding and classified research, concentrating benefits among well-connected companies.
The full analysis lists 5 implications of this text.
Who stands to gain
biotechnology companies (BIIB, Ginkgo Bioworks, Zymergen, Intrexon/Precigen, etc.); defense contractors with biotech divisions; academic research institutions with biotech programs